Anthem Biosciences Limited (ANTHEM) — FY26 Annual Report | 30 June 2026

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

Anthem Biosciences Limited voluntarily published its Business Responsibility and Sustainability Report (BRSR) for FY 2025-26, aligning with SEBI's upcoming mandatory requirements. The report details consolidated disclosures on governance, environmental impact, social initiatives, and stakeholder engagement. Key highlights include 100% renewable energy adoption efforts, ZLD implementation across three plants, 85% export revenue contribution, and a 16% cost allocation to employee well-being measures. The company emphasizes climate risk mitigation through energy efficiency projects and maintains strict anti-corruption and safety protocols. Independent limited assurance was provided by Vinay and Keshava LLP on the BRSR disclosures.

📄 View Original Announcement (PDF)

About Anthem Biosciences Limited (ANTHEM)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹53,084.93 Cr P/E: 91.9 ROE: 18.9% ROCE: 25.5% Div Yield: 0.21%

View full ANTHEM stock details →

📡 Get AI alerts when ANTHEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ANTHEM — Free

📊 More ANTHEM filings

See all ANTHEM filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ANTHEM files new disclosures

Track ANTHEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ANTHEM — Free

Free account · 2 AI queries/day